ArticleApplied biochemistry and biotechnology2025
High-Sensitivity Blood Cell Detection via Terahertz Refractive Index Sensing in Biomedical Applications.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Terahertz Modulation of Biomolecular Dynamics: Physical Mechanisms, Biological Implications, and Future Challenges.Research (Washington, D.C.) · 2026Review
- Plasmonic SPR biosensor with bayesian regression for non-invasive protein biomarker detection.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biosensors are essential tools for detecting and analyzing various elements of human biology. This study introduces an innovative circular-shaped photonic crystal fiber (PCF) with a hexahedron core for the precise detection of blood components. The sensor's performance evaluated using COMSOL Multiphysics software. The finite element methods (FEM) is applied to solve Maxwell's equations and perform simulations across a terahertz (THz) frequency range from 1.0 to 3.0 THz. This comprehensive investigation focuses on optimizing several important optical parameters, including relative sensitivity (RS), confinement loss (CL), effective mode area (EMA), and birefringence, etc. for enhancing the detection of various blood components. The Optical sensor is constructed by Topas as cladding material. The sensor demonstrates exceptional performance with RS of approximately 95.02% for glucose, 95.48% for plasma, 96.30% for white blood cells (WBCs), and 97.04% for red blood cells (RBCs) at an operational frequency of 2.20 THz. Thus the proposed sensor can provide reliable and accurate measurements across different blood components in advanced biomedical applications.
Indexed as
Identifiers
40402348What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.